These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 6934709
21. Prolymphocytic leukemia: diagnosis and treatment. A case report. Akin C, Hansen P, Janckila A. J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933 [Abstract] [Full Text] [Related]
22. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia. Jones B, Holland JF, Glidewell O, Jacquillat C, Weil M, Pochedly C, Sinks L, Chevalier L, Maurer HM, Koch K, Falkson G, Patterson R, Seligman B, Sartorius J, Kung F, Haurani F, Stuart M, Burgert EO, Ruymann F, Sawitsky A, Forman E, Pluess H, Truman J, Hakami N. Med Pediatr Oncol; 1977 Nov; 3(4):387-400. PubMed ID: 337095 [No Abstract] [Full Text] [Related]
23. Ineffectiveness of laetrile in the treatment of acute lymphoblastic leukemia. Mehta P. Clin Pediatr (Phila); 1980 May; 19(5):363-4. PubMed ID: 6928814 [Abstract] [Full Text] [Related]
25. Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemia. Land VJ, Sutow WW, Dyment PG, Falletta JM, Morgan SK, Bryan J. Med Pediatr Oncol; 1976 May; 2(2):191-8. PubMed ID: 1066523 [Abstract] [Full Text] [Related]
29. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna. Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, Kusec R, Morabito F, Iacopino P, Lutz D. Cancer; 1997 Jun 01; 79(11):2107-14. PubMed ID: 9179056 [Abstract] [Full Text] [Related]
31. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Yap BS, McCredie KB, Keating MJ, Bodey GP, Freireich EJ. Cancer Treat Rep; 1981 Jun 01; 65 Suppl 1():83-7. PubMed ID: 6948610 [Abstract] [Full Text] [Related]
32. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. Bassan R, Pogliani E, Lerede T, Fabris P, Rossi G, Morandi S, Casula P, Lambertenghi-Deliliers G, Vespignani M, Izzi T, Coser P, Corneo G, Barbui T. Haematologica; 1999 Dec 01; 84(12):1088-93. PubMed ID: 10586210 [Abstract] [Full Text] [Related]
36. Formal discussion of J. H. Burchenal's paper, "Success and failure in present chemotherapy and the implications of asparaginase". Holland JF. Cancer Res; 1969 Dec 01; 29(12):2270-1. PubMed ID: 5263332 [No Abstract] [Full Text] [Related]
38. Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. Pui CH, Jackson CW, Chesney CM, Abildgaard CF. Am J Hematol; 1987 Jul 01; 25(3):291-8. PubMed ID: 3111251 [Abstract] [Full Text] [Related]